Latest Story

Shares in Novo Nordisk spike as regulator backs high doses of weight-loss jab

By Abigail Townsend

Date: Friday 16 Jan 2026

(Sharecast News) - Shares in Novo Nordisk sparked on Friday, after the UK health authority approved higher doses of the Danish firm's blockbuster weight-loss treatment Wegovy.
Currently, doctors are unable to prescribe more than 2.4 milligrams of the jab a week for patients with obesity.

However, the Medicines and Healthcare...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page